DI STEFANO, ROSARIO FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.255
EU - Europa 843
AS - Asia 591
OC - Oceania 68
AF - Africa 55
SA - Sud America 23
Totale 2.835
Nazione #
US - Stati Uniti d'America 1.198
IT - Italia 232
CN - Cina 163
SG - Singapore 150
GB - Regno Unito 133
IE - Irlanda 123
SE - Svezia 69
AU - Australia 67
CA - Canada 45
IN - India 40
DE - Germania 34
ES - Italia 32
KR - Corea 32
IR - Iran 31
VN - Vietnam 29
PL - Polonia 28
UA - Ucraina 26
HK - Hong Kong 25
BE - Belgio 24
ID - Indonesia 23
TR - Turchia 22
DK - Danimarca 20
FR - Francia 19
JP - Giappone 19
NL - Olanda 16
PK - Pakistan 13
FI - Finlandia 12
CH - Svizzera 11
AT - Austria 10
PH - Filippine 10
ZA - Sudafrica 10
GH - Ghana 9
NG - Nigeria 9
BR - Brasile 8
IQ - Iraq 8
KE - Kenya 8
MX - Messico 8
RS - Serbia 8
TW - Taiwan 8
LT - Lituania 7
PT - Portogallo 7
CZ - Repubblica Ceca 6
GR - Grecia 6
CO - Colombia 5
EG - Egitto 5
IL - Israele 5
MA - Marocco 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
CL - Cile 3
HR - Croazia 3
HU - Ungheria 3
LY - Libia 3
MY - Malesia 3
TN - Tunisia 3
VE - Venezuela 3
AR - Argentina 2
BJ - Benin 2
KZ - Kazakistan 2
MT - Malta 2
NE - Niger 2
NI - Nicaragua 2
PR - Porto Rico 2
RO - Romania 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
EC - Ecuador 1
JO - Giordania 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 2.835
Città #
Chandler 193
Dublin 120
Singapore 115
Santa Clara 77
Ashburn 55
Fairfield 54
Nyköping 53
Beijing 45
Torino 36
Turin 36
Redwood City 32
Columbus 29
London 26
Wilmington 26
New York 25
Woodbridge 25
Seattle 22
Binbrook 20
Houston 20
Medford 20
Pisa 20
Princeton 20
Jakarta 18
Kalundborg 18
Cambridge 17
Dong Ket 16
Peoria 16
Fremont 14
Warsaw 14
Chennai 13
Hangzhou 13
Los Angeles 13
Milan 13
Guangzhou 12
Brisbane 11
Seoul 11
Shanghai 11
Dearborn 10
Genoa 9
Philadelphia 9
Istanbul 8
Madrid 8
San Diego 8
Tokyo 8
Vienna 8
Adelaide 7
Boston 7
Central 7
Gangdong-gu 7
Hong Kong 7
Isfahan 7
Jacksonville 7
Liverpool 7
Sydney 7
Taipei 7
Ann Arbor 6
Belgrade 6
Boardman 6
Chengdu 6
Chicago 6
Derby 6
Duncan 6
Kraków 6
Lappeenranta 6
Munich 6
Nairobi 6
Noblesville 6
Wuhan 6
Bognor Regis 5
Bronx 5
Camden 5
Davao City 5
Ghent 5
Helsinki 5
Hyderabad 5
Johannesburg 5
Kolkata 5
Melbourne 5
Shijiazhuang 5
Staten Island 5
Valencia 5
Abuja 4
Brussels 4
Buffalo 4
Croydon 4
Edmonton 4
Jerusalem 4
Jinan 4
Lahore 4
Manchester 4
Molenbeek-Saint-Jean 4
Moncalieri 4
Montreal 4
Odunpazari 4
Palo Alto 4
Perth 4
Piemonte 4
Rome 4
Tehran 4
Wuxi 4
Totale 1.636
Nome #
Hormonal treatment and quality of life of prostate cancer patients: new evidences 747
Renal cell carcinoma (RCC): Fatter is better? A review on the role of obesity in RCC 244
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018 189
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 164
Fatigue in lung cancer patients: symptom burden and management of challenges. 141
Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data 109
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018 100
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit 99
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate 97
LATITUDE and other coordinates in quality of life of prostate cancer patients 87
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave 82
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018 67
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel 66
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences 57
Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review 53
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives 53
Are tyrosine kinase inhibitors an effective treatment in testicular metastases from kidney cancer? Case report 52
Prognostic factors in metastatic castration resistant prostate cancer patients treated with Radium-223: a retrospective study 50
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis 48
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with Abiraterone or Enzalutamide 46
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine? 44
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? 43
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy 40
Therapeutic sequencing in advanced renal cell carcinoma: how to choose considering clinical and biological factors 37
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications 37
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond 33
Prognostic role of early PSa drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide 33
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy? 31
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma 19
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer 19
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis 13
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives 10
Totale 2.910
Categoria #
all - tutte 10.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020134 0 0 0 0 9 21 15 19 19 20 13 18
2020/2021335 12 17 33 33 39 25 26 33 30 27 17 43
2021/2022411 40 18 20 9 15 6 22 25 19 57 128 52
2022/2023852 52 90 33 59 84 152 57 63 99 51 65 47
2023/2024580 52 71 41 58 32 83 62 40 9 42 35 55
2024/2025435 47 84 62 87 155 0 0 0 0 0 0 0
Totale 2.910